Clinical Trial: A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07840326) titled 'A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)' on Sept. 18.

Brief Summary: The goal of this Phase 2 clinical trial is to investigate the safety and tolerability of SUN-627 in men and women aged 18-70 years old with a diagnosis of non-active SPMS/PPMS.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Primary Progressive Multiple Sclerosis Primary Progressive MS Primary Progressive Multiple Sclerosis (PPMS) Secondary Progressive MS (SPMS) Secondary Progressive Multiple Sclerosis (SPMS) Secondary Progressive MS Non-Active S...